Eagle Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eagle Pharmaceuticals

09/08/2021 12:33

* Eagle Pharmaceuticals Inc  EGRX.OQ  reported quarterly
adjusted earnings of 93 cents​​ per share for the quarter ended
in June. The mean expectation of four analysts for the quarter
was for earnings of 80 cents per share.
* Revenue rose 14.8% to $48.12 million from a year ago; 
analysts expected $45.86 million. 
* Eagle Pharmaceuticals Inc's reported EPS for the quarter was
27 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Eagle Pharmaceuticals Inc shares had risen by 6.9% this
quarter and lost 1.7% so far this year.
* The company reported quarterly net income of $3.61 million.
* Wall Street's median 12-month price target for Eagle
Pharmaceuticals Inc is $46.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 11:33 a.m.  ​All
figures in US dollars unless otherwise stated